Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does reduced kidney function raise plasma homocysteine levels?

Reduced kidney function impairs renal metabolic clearance of homocysteine and leads to higher plasma homocysteine concentrations.

SupportedJune 19, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Reduced kidney function decreases homocysteine clearance and is associated with higher plasma homocysteine concentrations.

laying out figure…
All 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that declining renal function compromises the kidney's ability to metabolize and extract homocysteine, causing systemic accumulation. Mechanistically, impaired intrarenal pathways—particularly decreased tubular metabolism via transsulfuration and remethylation—reduce overall clearance and drive elevated circulating homocysteine as kidney function worsens.

Verified conclusion

The kidney plays a critical role in the metabolic regulation of homocysteine, and its dysfunction is a primary driver of elevated plasma levels. Research consistently demonstrates that as renal function declines, the body's ability to clear and metabolize homocysteine is compromised, leading to its systemic accumulation.

Clinical evidence and effectiveness

There is a robust, inverse correlation between kidney function and plasma homocysteine concentrations.

  • Correlation and Prevalence: Studies show a strong inverse relationship between estimated glomerular filtration rate (eGFR) and homocysteine levels (correlation coefficients ranging from -0.424 to -0.61). In patients with end-stage renal disease (ESRD), homocysteine concentrations can be 3 to 5 times higher than in those with normal renal function.
  • Predictive Markers: Serum homocysteine rises concurrently with markers of renal decline, such as Cystatin C and creatinine. In large cohort studies (n > 16,000), kidney function has been found to mediate over 41% of the variation in plasma homocysteine levels.
  • Progression: In diabetic nephropathy and H-type hypertension, homocysteine levels increase progressively as the stage of renal impairment advances.

Mechanistic explanations

The relationship is driven by the kidney's role as a major metabolic hub rather than simple urinary excretion.

  • Metabolic Clearance: While less than 1% of homocysteine is cleared through direct urinary excretion, the kidneys are responsible for metabolizing approximately 70% of circulating homocysteine.
  • Intrarenal Pathways: Proximal tubular epithelial cells take up homocysteine from the blood via specific transporters (e.g., system $b^{0,i}$). Once inside the cell, homocysteine is degraded through the transsulfuration pathway (utilizing enzymes like cystathionine $\beta$-synthase) or recycled via remethylation.
  • Impairment Mechanism: Reduced kidney function impairs these intrarenal metabolic pathways and reduces the overall extraction of homocysteine from the circulation, leading to hyperhomocysteinemia.

Bottom line

Reduced kidney function is a definitive cause of increased plasma homocysteine concentrations due to impaired renal metabolic clearance. For a 44-year-old female, monitoring renal markers (eGFR, creatinine) is essential when assessing elevated homocysteine levels, as even mild renal impairment can significantly alter homocysteine metabolism.

References

  1. The importance of homocysteine levels in the prognosis of patients with chronic renal disease and in hemodialysis patients — gnresearch.org ↗
  2. The Analysis of Asymetric Dimethylarginine and Homocysteine in Patients with Chronic Kidney Disease — inabj.org ↗
  3. Homocysteine, system b0,+ and the renal epithelial transport and toxicity of inorganic mercury. — pmc.ncbi.nlm.nih.gov ↗
  4. The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function. — linkinghub.elsevier.com ↗
  5. The relationship between serum uric acid and homocysteine is influenced by kidney function. — linkinghub.elsevier.com ↗
  6. NORMAL HOMOCYSTEINE LEVELS IN WELL‐FUNCTIONING OLDEST‐OLD INDIVIDUALS DESPITE LOW KIDNEY FUNCTION — pmc.ncbi.nlm.nih.gov ↗
  7. Associations of Homocysteine with B Vitamins and Zinc in Serum Levels of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. — jstage.jst.go.jp ↗
  8. Correlation between Serum Homocysteine Level and Cystatin C Elevation in Patients with H-type Hypertension — mrhk.cc ↗
  9. Serum Homocysteine, cystatin C as Biomarkers for Progression of Diabetic Nephropathy — degruyter.com ↗
  10. Ischemia/Reperfusion Reduces Transcription Factor Sp1-mediated Cystathionine β-Synthase Expression in the Kidney* — linkinghub.elsevier.com ↗
  11. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→